| Schedule of segment reporting information, by segment |
| | | | | | | | | For the three months ended | | | September 30, | | | 2022 | | 2021 | Revenue | | | | | | | XpresSpa | | $ | 3,557 | | $ | 1,416 | XpresTest | | | 6,079 | | | 25,351 | Treat | | | 425 | | | — | HyperPointe | | | 675 | | | — | Corporate and other | | | — | | | — | Total revenue | | $ | 10,736 | | $ | 26,767 | | | | | | | | | | | | | | | Operating income (loss) | | | | | | | XpresSpa | | $ | (2,508) | | $ | (1,595) | XpresTest | | | (1,692) | | | 12,015 | Treat | | | (1,282) | | | (2,305) | HyperPointe | | | (193) | | | — | Corporate and other | | | (1,979) | | | (1,058) | Total operating (loss) income | | $ | (7,654) | | $ | 7,057 | | | | | | | | | | | | | | | | | | | | | | Depreciation & Amortization | | | | | | | XpresSpa | | $ | 364 | | $ | 340 | XpresTest | | | 576 | | | 509 | Treat | | | 520 | | | — | HyperPointe | | | 86 | | | — | Corporate and other | | | 18 | | | 3 | Total Depreciation & Amortization | | $ | 1,564 | | $ | 852 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the nine months ended | | | September 30, | | | 2022 | | 2021 | Revenue | | | | | | | XpresSpa | | $ | 9,490 | | $ | 2,172 | XpresTest | | | 35,928 | | | 42,199 | Treat | | | 1,110 | | | — | HyperPointe | | | 1,853 | | | — | Corporate and other | | | — | | | — | Total revenue | | $ | 48,381 | | $ | 44,371 | | | | | | | | | | | | | | | | | | | | | | Operating loss | | | | | | | XpresSpa | | $ | (8,921) | | $ | (4,828) | XpresTest | | | 2,576 | | | 14,597 | Treat | | | (4,038) | | | (4,115) | HyperPointe | | | (745) | | | — | Corporate and other | | | (6,744) | | | (3,719) | Total operating (loss) income | | $ | (17,872) | | $ | 1,935 | | | | | | | | | | | | | | | | | | | | | | Depreciation & Amortization | | | | | | | XpresSpa | | $ | 1,065 | | $ | 931 | XpresTest | | | 1,711 | | | 1,604 | Treat | | | 1,287 | | | — | HyperPointe | | | 243 | | | — | Corporate and other | | | 23 | | | 7 | Total depreciation & amortization | | $ | 4,329 | | $ | 2,542 | | | | | | | | | | | | | | | | | | | | | | Capital Expenditures | | | | | | | XpresSpa | | $ | 1,413 | | $ | 706 | XpresTest | | | 675 | | | 3,984 | Treat | | | 3,329 | | | — | HyperPointe | | | — | | | — | Corporate and other | | | 55 | | | 77 | Total capital expenditures | | $ | 5,472 | | $ | 4,767 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | September 30, | | December 31, | | | 2022 | | 2021 | Long-lived Assets | | | | | | | XpresSpa | | $ | 14,203 | | | 8,419 | XpresTest | | | 112 | | | 2,246 | Treat | | | 6,280 | | | 2,700 | HyperPointe | | | 123 | | | — | Corporate and other | | | 522 | | | 1,132 | Total long-lived Assets | | $ | 21,240 | | $ | 14,497 | | | | | | | | | | September 30, | | December 31, | | | 2022 | | 2021 | Assets | | | | | | | XpresSpa | | $ | 21,348 | | $ | 12,351 | XpresTest | | | 5,356 | | | 19,349 | Treat | | | 9,822 | | | 5,918 | HyperPointe | | | 7,126 | | | — | Corporate and other | | | 41,324 | | | 89,648 | Total assets | | $ | 84,976 | | $ | 127,266 |
|